As INOVOTION will take active part in 5th Antibody Industrial Symposium (AIS2017), June 27th-28th, take advantage of our presence in Tours to meet our team and learn more about INOVOTION’s unique drug discovery in vivo platform.
During Pitch Session of the 5th AIS, New ADC Formats: Diagnostic and Immunomonitoring, our CEO, Jean Viallet, will present INOVOTION Tests for drug discovery: Early identification of low value ADC. If you want to know more about these, and other results achieved by INOVOTION up to now, send us an email to contact@invovotion.com.
INOVOTION will also use this opportunity to meet the scientists from the University François Rabelais (Tours).
